76 Episoder

  1. Survey Says: Proceeding After Unsuccessful Treatment

    Udgivet: 19.3.2025
  2. Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation

    Udgivet: 24.2.2025
  3. Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye

    Udgivet: 29.1.2025
  4. Survey Says: Treatment for a High-Risk Patient

    Udgivet: 19.12.2024
  5. Chronic Stress and Glaucomatous Progression • Advances in Eye Drop Aids

    Udgivet: 25.11.2024
  6. Improving the Affordability of Glaucoma Medications

    Udgivet: 25.10.2024
  7. Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings

    Udgivet: 16.10.2024
  8. Survey Says: Next Steps for Slowly Progressive Disease

    Udgivet: 19.9.2024
  9. Masqueraders of Normal-Tension Glaucoma

    Udgivet: 23.8.2024
  10. DARC: From Bench to Bedside

    Udgivet: 22.7.2024
  11. Is Glaucoma Policy Short-Sighted?

    Udgivet: 24.6.2024
  12. Back to Basics: Patient Encounters in Glaucoma

    Udgivet: 5.6.2024
  13. Clinical Experiences With the Hydrus Microstent

    Udgivet: 29.5.2024
  14. Survey Says: Fluctuating IOP and Poor Compliance

    Udgivet: 28.5.2024
  15. Establishing a Glaucoma Practice Fresh Out of Fellowship

    Udgivet: 22.4.2024
  16. Advanced Cataract Technologies in Glaucomatous Eyes

    Udgivet: 22.3.2024
  17. Learning and Teaching MIGS

    Udgivet: 23.2.2024
  18. Survey Says: Which Treatment Next?

    Udgivet: 18.1.2024
  19. Clinical Experiences With the Hydrus Microstent

    Udgivet: 28.12.2023
  20. Geographic Atrophy: Future Treatment Paradigms

    Udgivet: 11.12.2023

1 / 4

Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.

Visit the podcast's native language site